Abiopharma

🔍 Redondo Jerry L (Executive)

Company: DUCOMMUN INC /DE/ (DCO)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Sold 748 shares of Common Stock at $137.23 per share (Direct)
  Date: 2026-05-08 | Code: F | equity_swap_involved: false | shares_owned_after: 70,285.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 759 shares of Common Stock (Direct)
  Date: 2026-05-08 | Code: D | equity_swap_involved: false | shares_owned_after: 69,526.00 | transaction_form_type: 4 | Footnotes: F2, F2

Footnotes:

• F1: Represents a reduction in shares to satisfy the tax withholding obligations of the Issuer with respect to the settlement, on May 8, 2026, of 1,507 restricted stock units.
• F2: In connection with the operation of the Issuer's Second Amended and Restated Clawback Policy (the "Clawback Policy") with respect to the restatement and revision of the Issuer's previously issued financial statements, as reported in the Issuer's Form 8-K filed on May 1, 2026, the Issuer determined that the Reporting Person would not have earned certain compensation had such compensation been determined based on the restated financial statements. As a result, 1,507 restricted stock units that vested on May 8, 2026 were not delivered to the Reporting Person and 759 shares of Issuer common stock were returned to the Issuer in accordance with the Issuer's Clawback Policy.